Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platinum-Pemetrexed-Atezolizumab (+/- Bevacizumab) in Advanced NSCLC With Targetable Mutations Progressing After Targeted Therapies
NCT04042558Phase 2Completed
- Sponsor
- Centre François Baclesse
- Start
- Sep 2019
- Primary completion
- Oct 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in non-small cell lung cancer (NSCLC), sponsored by Centre François Baclesse. Started Sep 2019; status: completed.
02
Drugs
atezolizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04042558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04042558.